Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126661291 | 12666129 | 1 | I | 20160323 | 20160818 | 20160818 | PER | US-JAZZ-2016-US-005697 | JAZZ | 0.00 | F | Y | 0.00000 | 20160818 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126661291 | 12666129 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | 21196 | 2.25 | G | ORAL SOLUTION | |||||||
| 126661291 | 12666129 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | DOSE ADJUSTMENTS | 21196 | ORAL SOLUTION | |||||||||
| 126661291 | 12666129 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4.5 G, BID | 21196 | 4.5 | G | ORAL SOLUTION | |||||||
| 126661291 | 12666129 | 4 | SS | PROVIGIL | MODAFINIL | 1 | UNK | 0 | |||||||||||
| 126661291 | 12666129 | 5 | C | Doxycycline monohydrate | DOXYCYCLINE | 1 | U | 0 | |||||||||||
| 126661291 | 12666129 | 6 | C | FLUOCINONIDE. | FLUOCINONIDE | 1 | U | 0 | |||||||||||
| 126661291 | 12666129 | 7 | C | Brompheniramine- Pseudoephedrine dm | 2 | U | 0 | ||||||||||||
| 126661291 | 12666129 | 8 | C | ZITHROMAX | AZITHROMYCIN DIHYDRATE | 1 | U | 0 | |||||||||||
| 126661291 | 12666129 | 9 | C | KETOROLAC | KETOROLACKETOROLAC TROMETHAMINE | 1 | U | 0 | |||||||||||
| 126661291 | 12666129 | 10 | C | ROBAXIN | METHOCARBAMOL | 1 | U | 0 | |||||||||||
| 126661291 | 12666129 | 11 | C | Nitrofurantoin mcr | 2 | U | 0 | ||||||||||||
| 126661291 | 12666129 | 12 | C | MECLIZINE | MECLIZINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 126661291 | 12666129 | 13 | C | NUVIGIL | ARMODAFINIL | 1 | U | 0 | |||||||||||
| 126661291 | 12666129 | 14 | C | RITALIN | METHYLPHENIDATE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 126661291 | 12666129 | 15 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | U | 0 | |||||||||||
| 126661291 | 12666129 | 16 | C | Np thyroid | LEVOTHYROXINELIOTHYRONINE | 1 | U | 0 | |||||||||||
| 126661291 | 12666129 | 17 | C | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | U | 0 | |||||||||||
| 126661291 | 12666129 | 18 | C | XOPENEX HFA | LEVALBUTEROL TARTRATE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126661291 | 12666129 | 1 | Narcolepsy |
| 126661291 | 12666129 | 2 | Cataplexy |
| 126661291 | 12666129 | 4 | Somnolence |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126661291 | 12666129 | Fear | |
| 126661291 | 12666129 | Unevaluable event |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126661291 | 12666129 | 1 | 201407 | 201407 | 0 | |
| 126661291 | 12666129 | 3 | 201505 | 0 |